Sara Bonstein's Net Worth

$15.6 Million

Estimate Recalculated Jun 18, 2025 08:57PM EST

Who is Sara Bonstein

Sara Bonstein has an estimated net worth of $15.6 Million. This is based on reported shares across multiple companies, which include INSMED Inc, Xilio Therapeutics, Inc., Advaxis, Inc., scPharmaceuticals Inc., and ONCOSEC MEDICAL Inc.

SEC CIK

Sara Bonstein's CIK is 0001604019

Past Insider Trading and Trends

2024 was Sara Bonstein's most active year for acquiring shares with 18 total transactions. Sara Bonstein's most active month to acquire stocks was the month of April. 2024 was Sara Bonstein's most active year for disposing of shares, totalling 16 transactions. Sara Bonstein's most active month to dispose stocks was the month of April. 2024 saw Sara Bonstein paying a total of $6,405,459.05 for 448,149 shares, this is the most they've acquired in one year. In 2024 Sara Bonstein cashed out on 498,161 shares for a total of $12,476,577.86, their largest year based on trade value.

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

INSMED Inc

Chief Financial Officer

Updated May 30, 2024

View Quote Details


Form 4	-46.76%	-241.29K	$38.28	-$5.66M	May 30, 2024	274.76K	Sale	Scheduled	May 28 - May 29
Form 4	65.40%	74.59K	$25.32	-$280.75K	May 15, 2024	188.64K	Grant	—	May 13 - May 14
Form 4	-3.79%	-4.50K	$29.18	-$131.22K	Jan 11, 2024	114.05K	Sale	—	Jan 09
Form 4	72.33%	76.43K	—	—	Jan 05, 2024	182.11K	Grant	—	Jan 04
Form 4	-11.14%	-13.20K	$30.00	-$395.97K	Dec 22, 2023	105.24K	Sale	Scheduled	Dec 22
Form 4	-3.15%	-3.82K	$18.95	-$72.39K	May 17, 2023	117.62K	Sale	—	May 15 - May 16
Form 4	323.81%	213.82K	—	—	May 15, 2023	279.85K	Grant	—	May 11
Form 4	-4.15%	-2.86K	$18.12	-$51.77K	Jan 12, 2023	66.03K	Sale	—	Jan 10
Form 4	91.84%	51.06K	—	—	Jan 06, 2023	106.65K	Grant	—	Jan 05
Form 4	-2.55%	-1.43K	$18.51	-$26.52K	May 18, 2022	54.68K	Sale	—	May 16
Form 4	319.90%	115.10K	—	—	May 13, 2022	151.08K	Grant	—	May 11
Form 4	-3.11%	-1.15K	$25.11	-$28.98K	Jan 13, 2022	35.98K	Sale	—	Jan 11
Form 4	314.36%	75.85K	—	—	Jan 10, 2022	99.97K	Grant	—	Jan 06
Form 4	901.80%	82.81K	—	—	May 14, 2021	92.00K	Grant	—	May 12
Form 4	—	54.78K	—	—	Jan 08, 2021	54.78K	Grant	—	Jan 07
Form 4	—	34.89K	—	—	May 14, 2020	34.89K	Grant	—	May 12
Form 4	—	91.64K	—	—	Feb 05, 2020	91.64K	Grant	—	Feb 03
Form 3	—	—	—	—	Feb 05, 2020	—	—	—	—

Showing 18 results

Xilio Therapeutics, Inc.

Investor

Updated Jun 17, 2024

View Quote Details


Form 4	—	25.00K	—	—	Jun 17, 2024	25.00K	Grant	—	Jun 14
Form 4	—	13.20K	—	—	Jun 13, 2023	13.20K	Grant	—	Jun 12
Form 4	—	13.20K	—	—	Jun 17, 2022	13.20K	Grant	—	Jun 15
Form 3	—	—	—	—	Oct 21, 2021	—	—	—	—

Showing 4 results

Advaxis, Inc.

Chief Financial Officer

Updated Apr 03, 2018

View Quote Details


Form 4	0.48%	1.09K	$1.69	$1.84K	Apr 03, 2018	226.67K	Grant	—	Mar 29
Form 4	0.44%	989.00	$1.86	$1.84K	Mar 01, 2018	225.58K	Grant	—	Feb 28
Form 4	-0.26%	-580.00	$2.96	-$1.72K	Feb 02, 2018	224.59K	Grant	—	Jan 31
Form 4	-2.08%	-4.75K	$3.01	-$15.27K	Jan 03, 2018	224.01K	Sale	—	Dec 29 - Jan 03
Form 4	0.38%	856.00	$2.99	$2.56K	Dec 04, 2017	228.76K	Grant	—	Nov 30
Form 4	41.48%	96.14K	$3.30	-$12.74K	Nov 06, 2017	327.91K	Grant	—	Nov 02 - Nov 06
Form 4	-5.06%	-12.36K	$3.30	-$39.33K	Nov 02, 2017	231.77K	Sale	—	Oct 31 - Nov 02
Form 4	0.17%	423.00	$4.18	$1.77K	Oct 02, 2017	244.13K	Grant	—	Sep 29
Form 4	0.11%	273.00	$6.81	$1.86K	Sep 05, 2017	243.70K	Grant	—	Aug 31
Form 4	0.12%	280.00	$6.47	$1.81K	Aug 01, 2017	243.43K	Grant	—	Jul 31
Form 4	0.16%	394.00	$6.49	$2.56K	Jul 03, 2017	243.15K	Grant	—	Jun 30
Form 4	30.83%	57.20K	—	—	Jun 20, 2017	242.76K	Grant	—	Jun 19
Form 4	0.12%	219.00	$8.07	$1.77K	Jun 01, 2017	185.56K	Grant	—	May 31
Form 4	45.62%	58.07K	$8.56	$1.58K	May 01, 2017	185.34K	Grant	—	Apr 28 - May 01
Form 4	0.15%	194.00	$8.17	$1.58K	Apr 03, 2017	127.27K	Grant	—	Mar 31
Form 4	0.16%	202.00	$8.79	$1.78K	Mar 01, 2017	127.08K	Grant	—	Feb 28
Form 4	0.15%	194.00	$8.96	$1.74K	Feb 02, 2017	126.88K	Grant	—	Jan 31
Form 4	54.56%	44.72K	$7.26	-$38.98K	Jan 03, 2017	126.68K	Grant	—	Dec 30
Form 4	0.23%	190.00	$8.31	$1.58K	Dec 01, 2016	81.96K	Grant	—	Nov 30
Form 4	—	68.91K	—	—	Nov 07, 2016	68.91K	Grant	—	Nov 03
Form 4	0.24%	196.00	$8.09	$1.59K	Nov 02, 2016	81.77K	Grant	—	Oct 31
Form 4	0.18%	148.00	$10.69	$1.58K	Oct 04, 2016	81.58K	Grant	—	Sep 30
Form 4	0.17%	137.00	$11.53	$1.58K	Sep 01, 2016	81.43K	Grant	—	Aug 31
Form 4	0.23%	190.00	$8.34	$1.58K	Aug 01, 2016	81.29K	Grant	—	Jul 29
Form 4	0.35%	282.00	$8.09	$2.28K	Jul 01, 2016	81.10K	Grant	—	Jun 30
Form 4	0.21%	171.00	$9.26	$1.58K	Jun 01, 2016	80.82K	Grant	—	May 31
Form 4	0.25%	204.00	$7.74	$1.58K	May 02, 2016	80.65K	Grant	—	Apr 29
Form 4	0.22%	175.00	$9.03	$1.58K	Apr 01, 2016	80.45K	Grant	—	Mar 31
Form 4	0.36%	290.00	$5.46	$1.58K	Mar 01, 2016	80.27K	Grant	—	Feb 29
Form 4	-15.83%	-15.04K	$5.58	-$83.91K	Feb 25, 2016	79.98K	Sale	—	Feb 24
Form 4	0.22%	205.00	$6.82	$1.40K	Feb 01, 2016	95.02K	Grant	—	Jan 29
Form 4	0.20%	186.00	$10.06	$1.87K	Jan 04, 2016	94.81K	Grant	—	Dec 31
Form 4	0.12%	114.00	$12.07	$1.38K	Dec 01, 2015	94.63K	Grant	—	Nov 30
Form 4	—	160.00K	—	—	Nov 06, 2015	160.00K	Grant	—	Nov 05
Form 4	0.13%	118.00	$11.09	$1.31K	Nov 03, 2015	94.52K	Grant	—	Oct 30
Form 4	0.14%	129.00	$10.23	$1.32K	Oct 01, 2015	94.40K	Grant	—	Sep 30
Form 4	0.09%	89.00	$14.80	$1.32K	Sep 02, 2015	94.27K	Grant	—	Aug 31
Form 4	0.12%	114.00	$16.66	$1.90K	Aug 04, 2015	94.18K	Grant	—	Jul 31
Form 4	0.07%	65.00	$20.33	$1.32K	Jul 01, 2015	94.07K	Grant	—	Jun 30
Form 4	0.06%	52.00	$25.16	$1.31K	Jun 02, 2015	94.00K	Grant	—	May 29
Form 4	0.08%	75.00	$16.81	$1.26K	May 01, 2015	93.95K	Grant	—	Apr 30
Form 4	267.82%	251.21K	$14.44	$1.11K	Apr 01, 2015	345.01K	Grant	—	Mar 30 - Mar 31
Form 4	0.13%	124.00	$9.00	$1.12K	Mar 02, 2015	93.80K	Grant	—	Feb 27
Form 4	-13.87%	-15.09K	$8.30	-$125.22K	Feb 25, 2015	93.67K	Tax	—	Feb 24
Form 4	26.44%	22.74K	$9.85	$1.47K	Feb 04, 2015	108.76K	Grant	—	Dec 10 - Jan 30
Form 4	0.16%	135.00	$8.01	$1.08K	Jan 02, 2015	86.02K	Grant	—	Dec 31
Form 4	0.40%	346.00	$3.12	$1.08K	Dec 01, 2014	85.88K	Grant	—	Nov 28
Form 4	0.40%	340.00	$3.18	$1.08K	Nov 03, 2014	85.54K	Grant	—	Oct 31
Form 4	0.38%	321.00	$3.36	$1.08K	Oct 01, 2014	85.20K	Grant	—	Sep 30
Form 4	0.33%	278.00	$3.88	$1.08K	Sep 02, 2014	84.88K	Grant	—	Aug 29
Form 4	0.64%	542.00	$2.84	$1.54K	Aug 01, 2014	84.60K	Grant	—	Aug 01
Form 4	7,513.68%	82.95K	$5.07	-$86.44K	Jul 18, 2014	84.06K	Grant	—	Jul 17
Form 4	111.49%	582.00	$3.15	-$762.30	Jul 01, 2014	1.10K	Grant	—	Jul 01
Form 4	—	522.00	$2.72	-$527.68	May 02, 2014	522.00	Grant	—	May 01
Form 3	—	—	—	—	Mar 31, 2014	—	—	—	—

Showing 55 results

scPharmaceuticals Inc.

Investor

Updated Jun 13, 2024

View Quote Details


Form 4	—	19.75K	—	—	Jun 13, 2024	19.75K	Grant	—	Jun 11
Form 4	—	17.30K	—	—	Jun 08, 2023	17.30K	Grant	—	Jun 06
Form 4	—	16.30K	—	—	Jun 15, 2022	16.30K	Grant	—	Jun 14
Form 4	—	16.30K	—	—	Jun 10, 2021	16.30K	Grant	—	Jun 08
Form 4	—	12.25K	—	—	Jul 13, 2020	12.25K	Grant	—	Jul 08
Form 3	—	—	—	—	Jul 13, 2020	—	—	—	—

Showing 6 results

ONCOSEC MEDICAL Inc

CFO/COO

Updated Jan 21, 2020

View Quote Details


Form 4	-3.16%	-1.35K	$2.08	-$2.81K	Jan 21, 2020	41.39K	Sale	—	Jan 16
Form 4	-2.53%	-1.11K	$2.01	-$2.23K	Oct 18, 2019	42.74K	Sale	—	Oct 16
Form 4	-2.47%	-1.11K	$2.42	-$2.69K	Jul 18, 2019	43.85K	Tax	—	Jul 16
Form 4	-2.41%	-11.10K	$0.60	-$6.66K	Apr 18, 2019	449.63K	Tax	—	Apr 16
Form 4	-2.82%	-13.38K	$0.69	-$9.16K	Jan 18, 2019	460.73K	Tax	—	Jan 16
Form 4	—	165.00K	—	—	Dec 27, 2018	165.00K	Grant	—	Dec 24
Form 4	-3.15%	-15.40K	$1.58	-$24.34K	Oct 18, 2018	474.11K	Tax	—	Sep 16
Form 4	—	489.51K	$1.34	-$181.55K	Jul 18, 2018	489.52K	Grant	—	Jul 16
Form 3	—	—	—	—	Jul 18, 2018	—	—	—	—

Showing 9 results